Attached files

file filename
EX-99.1 - EX-99.1 - UNITED SURGICAL PARTNERS INTERNATIONAL INCd492450dex991.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 27, 2013

 

 

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.

(Exact name of Registrant as specified in its charter)

 

 

 

Delaware   333-144337   75-2749762

(State or other

jurisdiction of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

15305 Dallas Parkway Suite 1600

Addison, Texas

  75001
(Address of principal executive offices)   (Zip code)

Registrant’s telephone number, including area code: (972) 713-3500

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 7.01 Regulation FD Disclosure.

Attached hereto is a presentation made by senior officers of United Surgical Partners International, Inc. (the “Company”) on February 27, 2013 at the J.P. Morgan Global High Yield & Leveraged Finance Conference 2013 in Miami Beach, Florida. A copy of the presentation is attached hereto as Exhibit 99.1. These materials are also available on the Company’s website at www.uspi.com.

In accordance with General Instruction B.2. of Form 8-K, the information furnished in this report on Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that Section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

  99.1 Presentation by the Company made on February 27, 2013 at the J.P. Morgan Global High Yield & Leveraged Finance Conference 2013 in Miami Beach, Florida


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.
By:   /s/ Jason B. Cagle
  Jason B. Cagle
  Chief Financial Officer
  (Principal Financial Officer and duly authorized
  to sign this report on behalf of the Registrant)

Date: February 27, 2013


EXHIBIT INDEX

 

Exhibit

Number

   Description
99.1    Presentation by the Company made on February 27, 2013 at the J.P. Morgan Global High Yield & Leveraged Finance Conference 2013 in Miami Beach, Florida